Format

Send to

Choose Destination
Rheumatology (Oxford). 2015 Oct;54(10):1932-4. doi: 10.1093/rheumatology/kev237. Epub 2015 Jul 2.

Treatment failure by canakinumab in a patient with progressive multisystemic Erdheim-Chester disease refractory to anakinra: successful use of vemurafenib.

Author information

1
Vasculitis Center, Department of Rheumatology and Clinical Immunology, Klinikum Bad Bramstedt and University Medical Center Schleswig-Holstein, Bad Bramstedt and j.schirmer@klinikumbb.de.
2
Institute for Pathology, University of Lübeck and University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
3
Vasculitis Center, Department of Rheumatology and Clinical Immunology, Klinikum Bad Bramstedt and University Medical Center Schleswig-Holstein, Bad Bramstedt and.
PMID:
26139656
DOI:
10.1093/rheumatology/kev237
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center